Medical Device Industry News

  • Smith & Nephew Wary of 'Mega-Merger'

    London-based Smith & Nephew plc, frequently brought up as an acquisition target, is going its own way, according to a report in the Telegraph.

  • FDA Plans to Close 510(k) Loophole

    Medtech manufacturers may soon have clearer guidelines on how to get their products through the FDA’s 510(k) process—with the changes meant to address the widespread criticism of the regulatory pathway in recent years by Congress, consumer advocates, and others.

  • Medtronic Has an Internal App-etite for Apple Products

    Medtech giant Medtronic apparently hasn’t slowed down on its appetite for using Apple technology internally—even as the iconic tech company is signaling its interest to compete more actively in the healthcare market.

  • Boston Scientific Merger Shy in Busy Period of M&A Deals

    Like the kid on the playground who watches others hop on and off the spinning merry-go-round, Boston Scientific says it will sit out the current whirl of medtech mergers.Following last week’s second-quarter earnings report, president and CEO Michael Mahoney told analysts that the Natick, MA–based company would continue to grow its business organically, with the possibility of a few “tuck-in” acquisitions to contribute to that growth.

  • 5 Recent Medical Device Failures

    From GE Healthcare carbon dioxide detectors with potentially incorrect values to Medtronic’s recall of a cerebrospinal fluid draining and monitoring device, July saw plenty of news when it came to serious medical device errors. And unfortunately, in the case of General Electric and Medtronic, these were companies that had seen their share of Class I-level recalls in recent years. Read on to find out more: 1. GE Hit with Another Class I—This Time over Carbon Dioxide Detectors

  • Medtronic Acquires Neurosurgery Firm Visualase

    On the heels of announcing its plans to acquire Covidien, Medtronic has expanded its neurosurgery footprint, completing its possibly $105 million acquisition of Visualase Inc. (Houston, TX). Previously a privately held company, Visualase develops and markets an FDA-approved MRI-guided system for minimally invasive neurosurgeries, including surgical thermal ablation for brain tumors and epilepsy.

  • CR Bard Eyes Acquisitions amid Medtronic-Covidien Deal

    CR Bard execs know they have a gorilla of a competitor in the proposed $43 billion Medtronic acquisition of Covidien, particularly in the vascular business. They aren’t predicting the effects of that business combination on Bard, but are looking seriously at making some acquisitions of their own. They’re just going to tread carefully.

  • 3-D Scanning Makes Inroads in Medtech

    In early June, 3-D scanning specialist Artec (Palo Alto, CA) announced that it had struck a deal with the prosthetics firm Ottobock (Königsee, Germany). The announcement reflects growing popularity for 3-D scanning technology in the medical arena.

  • Boston Scientific Debuts Intravascular Image System

    Intravascular imaging may just have become easier for Boston Scientific (Marlborough, MA) iLAB customers.The company has launched a more powerful imaging device that could also reduce confusing workflows, shorten procedure times, and ease image interpretation,according to a press release. Physicians, nurses, technicians, and software design experts advised the company on the design.

  • Bioreactor Generates Platelets

    Blood-platelet shortages may become a thing of the past, according to scientists at Brigham and Women's Hospital in Boston. The researchers have designed an industrial-strength bone marrow bioreactor that can generate human platelets in vitro, according to a hospital press release.Their study appears in the July 21, 2014 issue of BLOOD.